By conjugating the QDs with antibodies targeting specific tumor features, they were able to monitor T-cell dynamics in the tumor microcirculation and to detect programmed cell death protein 1 and programmed death-ligand 1 (PD-L1) in tumors with cellular resolution. Here, PDCD1 is linked to neoplasm.